Nora Tu

699 total citations
26 papers, 472 citations indexed

About

Nora Tu is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Nora Tu has authored 26 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 5 papers in Genetics. Recurrent topics in Nora Tu's work include Acute Myeloid Leukemia Research (10 papers), Neutropenia and Cancer Infections (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Nora Tu is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Neutropenia and Cancer Infections (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). Nora Tu collaborates with scholars based in United States, Germany and France. Nora Tu's co-authors include Limin Shi, Paul H. Patterson, Mary Panaccio, Gerald V. Naccarelli, Christine Haller, Thomas E. Kearney, Maribel Salas, Zahidul Islam, Michelle D. Hackshaw and C.L. Beach and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Nora Tu

26 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nora Tu United States 9 138 89 75 64 61 26 472
Payal Shah United States 14 108 0.8× 94 1.1× 40 0.5× 32 0.5× 49 0.8× 54 588
Mai S. Sater Bahrain 15 75 0.5× 123 1.4× 19 0.3× 80 1.3× 29 0.5× 33 603
André W. Broekmans Netherlands 8 509 3.7× 59 0.7× 32 0.4× 51 0.8× 152 2.5× 15 828
M. Lombardo Italy 9 29 0.2× 49 0.6× 39 0.5× 70 1.1× 117 1.9× 35 453
M. Joseph John India 11 135 1.0× 100 1.1× 48 0.6× 29 0.5× 23 0.4× 61 522
P. H. Ananthanarayanan India 16 31 0.2× 41 0.5× 47 0.6× 39 0.6× 68 1.1× 25 449
Valeria Nucera Italy 12 54 0.4× 65 0.7× 27 0.4× 18 0.3× 24 0.4× 19 477
Ki Soon Kim South Korea 11 37 0.3× 115 1.3× 48 0.6× 70 1.1× 78 1.3× 21 580
Johana Béné France 12 60 0.4× 22 0.2× 64 0.9× 19 0.3× 48 0.8× 34 591

Countries citing papers authored by Nora Tu

Since Specialization
Citations

This map shows the geographic impact of Nora Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Tu more than expected).

Fields of papers citing papers by Nora Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Tu. The network helps show where Nora Tu may publish in the future.

Co-authorship network of co-authors of Nora Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Tu. A scholar is included among the top collaborators of Nora Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Tu. Nora Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salas, Maribel, et al.. (2024). Real-world drug utilization and treatment patterns in patients with tenosynovial giant cell tumors in the USA. Future Oncology. 20(16). 1079–1097. 2 indexed citations
2.
3.
4.
5.
Salas, Maribel, et al.. (2022). Health-related quality of life in women with breast cancer: a review of measures. BMC Cancer. 22(1). 66–66. 18 indexed citations
6.
Hackshaw, Michelle D., Heather E. Danysh, Nora Tu, et al.. (2021). Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review. BMC Cancer. 21(1). 967–967. 28 indexed citations
7.
8.
Salas, Maribel, et al.. (2021). Evaluation of patient/caregiver and healthcare provider knowledge, attitudes and behavior for safety and use of pexidartinib. Journal of Comparative Effectiveness Research. 10(12). 953–967. 4 indexed citations
9.
Salas, Maribel, et al.. (2020). Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers. Frontiers in Pharmacology. 11. 1109–1109. 7 indexed citations
10.
Hackshaw, Michelle D., et al.. (2020). Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer. Cancer Treatment and Research Communications. 24. 100189–100189. 2 indexed citations
11.
Salas, Maribel, et al.. (2020). Evaluation of patient and healthcare provider (HCP) knowledge, attitudes, and behavior for safety and use of pexidartinib.. Journal of Clinical Oncology. 38(15_suppl). e23580–e23580. 1 indexed citations
12.
Tu, Nora, Zahidul Islam, Albert Fliss, & Maribel Salas. (2019). An Evaluation of Major Comorbidities and Treatment Patterns of Newly Diagnosed Acute Myeloid Leukemia Patients: A Retrospective Analysis of Electronic Medical Records from US. Blood. 134(Supplement_1). 5106–5106. 1 indexed citations
13.
Döhner, Hartmut, Anna Dolnik, Lin Tang, et al.. (2018). Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care. Leukemia. 32(12). 2546–2557. 82 indexed citations
14.
Fathi, Amir T., Courtney D. DiNardo, Irina Kline, et al.. (2018). Alterations in serum bilirubin during enasidenib treatment in patients with or without UGT1A1 mutations.. Journal of Clinical Oncology. 36(15_suppl). e19003–e19003. 3 indexed citations
15.
16.
Komrokji, Rami S., Arlene S. Swern, David L. Grinblatt, et al.. (2017). Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies. The Oncologist. 23(2). 159–170. 27 indexed citations
17.
Schumi, Jennifer, et al.. (2016). Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data. American Journal of Cardiovascular Drugs. 16(6). 427–437. 1 indexed citations
18.
Naccarelli, Gerald V., et al.. (2012). CHADS2 and CHA2DS2-VASc Risk Factors to Predict First Cardiovascular Hospitalization Among Atrial Fibrillation/Atrial Flutter Patients. The American Journal of Cardiology. 109(10). 1526–1533. 58 indexed citations
19.
MacDiarmid, Scott, Andrew Chen, Nora Tu, Joseph W. Aquilina, & Kenneth M. Peters. (2006). 1639: Effects of Tamsulosin and Extended-Release Oxybutynin on Lower Urinary Tract Symptoms in Men. The Journal of Urology. 175(4S). 528–528. 3 indexed citations
20.
Fletcher, Jonathan A., Nora Tu, Ramana Tantravahi, & Stephen E. Sallan. (1992). Extremely Poor Prognosis of Pediatric Acute Lymphoblastic Leukemia with Translocation (9;22): Updated Experience. Leukemia & lymphoma. 8(1-2). 75–79. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Payal Shah Breakdown of academic impact, for papers by Mai S. Sater Breakdown of academic impact, for papers by André W. Broekmans Breakdown of academic impact, for papers by M. Lombardo Breakdown of academic impact, for papers by M. Joseph John Breakdown of academic impact, for papers by P. H. Ananthanarayanan Breakdown of academic impact, for papers by Valeria Nucera Breakdown of academic impact, for papers by Ki Soon Kim Breakdown of academic impact, for papers by Johana Béné
Rankless by CCL
2026